Jerome C. Bressi - San Diego CA, US Anthony R. Gangloff - San Diego CA, US Lily Kwok - San Diego CA, US
Assignee:
Takeda San Diego, Inc. - San Diego CA
International Classification:
C07D 231/56 A01N 43/56
US Classification:
5483625, 514406
Abstract:
Compounds, pharmaceutical compositions, kits and methods are provided for use with HDAC that comprise a compound selected from the group consisting of:.
Disclosed are compounds, pharmaceutical compositions, kits, articles of manufacture, methods of using, and methods of preparing compounds having the formula:.
Jerome C. Bressi - San Diego CA, US Shaosong Chu - San Diego CA, US Philip Erickson - San Diego CA, US Mallareddy Komandla - San Diego CA, US Lily Kwok - San Diego CA, US John D Lawson - Carlsbad CA, US Jeffrey A Stafford - San Diego CA, US Michael B. Wallace - San Diego CA, US Zhiyuan Zhang - Carlsbad CA, US Sanjib Das - Bangalore, IN
Assignee:
Takeda Pharmaceutical Company Limited - Osaka
International Classification:
A61K 31/50 A61K 31/495 C07D 487/04
US Classification:
514248, 544236
Abstract:
Compounds of the following formula are provided for use with cMET:.
Jerome Bressi - San Diego CA, US Anthony Gangloff - San Diego CA, US Lily Kwok - San Diego CA, US
International Classification:
C07D 231/12 A61K 31/415
US Classification:
514406000, 548373100
Abstract:
Compounds, pharmaceutical compositions, kits and methods are provided for use with HDAC that comprise a compound selected from the group consisting of: wherein the substituents are as defined herein.
Jerome Bressi - San Diego CA, US Anthony Gangloff - San Diego CA, US Lily Kwok - San Diego CA, US
International Classification:
C07D 231/54 C07D 231/10
US Classification:
548361100, 548375100
Abstract:
Compounds, pharmaceutical compositions, kits and methods are provided for use with HDAC that comprise a compound selected from the group consisting of: wherein the substituents are as defined herein.
Compounds, pharmaceutical compositions, kits and methods are provided for use with HDAC that comprise a compound selected from the group consisting of:wherein the substituents are as defined herein.
Compounds, pharmaceutical compositions, kits and methods are provided for use with HDAC that comprise a compound selected from the group consisting of:wherein the substituents are as defined herein.
Jerome C. Bressi - San Diego CA, US Anthony R. Gangloff - San Diego CA, US Lily Kwok - San Diego CA, US
International Classification:
C07D 249/16 C07D 207/30
US Classification:
548261, 548561, 5483751
Abstract:
Compounds, pharmaceutical compositions, kits and methods are provided for use with HDAC that comprise a compound selected from the group consisting of:wherein the substituents are as defined herein.